News & Analysis on Clinical Trial Services & Contract Research And Development
PEOPLE ON THE MOVE
By Melissa Fassbender
- Last updated on
The CDMO announced that Michael Mulhern has joined the company as CEO, succeeding William S. Marth, who will remain with the company in an advisory role.
Mulhern was previously CEO of Sterigenics International, a provider of contract sterilization, gamma technologies, and medical isotopes.
Since 2002, Mulhern has been CEO of three companies backed by GTCR, the private equity firm behind AMRI. In addition to Sterigenics International, he was CEO of Fairmont Food Group and American Sanitary.
He has also held roles at Baxter International and Alliant Foodservice.